The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis: A Consensus Statement
Abstract
New criteria for the diagnosis of multiple sclerosis (MS) were published as the result of an internationally formed committee. To increase the specificity of diagnosis and to minimize the number of false diagnoses, the committee recommended the use of both clinical and paraclinical criteria, the latter involving information obtained from magnetic resonance imaging, evoked potentials, and cerebrospinal fluid (CSF) analysis. Although rigorous magnetic resonance imaging requirements were provided, the "new criteria paper" fell short in terms of guidelines as to how the CSF analysis should be performed and simply equated the IgG index with isoelectric focusing, without any justification. The spectrum of parameters analyzed and methods for CSF analysis differ worldwide and often yield variable results in terms of sensitivity, specificity, accuracy, and reliability, with no decided "optimal" CSF test for the diagnosis of MS. To address this question specifically, an international panel of experts in MS and CSF diagnostic techniques was convened and the result was this article, representing a consensus of all the participants. These recommendations for establishing a standard for the evaluation of CSF in patients suspected of having MS should greatly complement the new criteria in ensuring that a correct diagnosis of MS is being made.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Multiple studies provide evidence that in adult patients with CIS, CSF OCBs are an independent predictor of the risk of a second attack when controlling for demographic, clinical, treatment, and MRI variables. 61-69”
From Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria (2018) · cites this paper as [64]
In the citing paper
“but in some patients, further supportive information can be obtained from cerebrospinal fluid examination and neurophysiological testing.”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [14]
In the citing paper
“Qualitative assessment of IgG using isoelectric focusing and immunofixation is the optimal method for detection of OCBs.14”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [14]
In the citing paper
“CSF findings in MS include a normal or mildly raised white cell count (<25 cells/cm 3 , predominantly lymphocytes) and protein (usually <1g/L), a raised IgG index and IgG oligoclonal bands (OCBs) not present in serum.14”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [14]
Citations
Cites
Tibbling, G., Link, H., & Ohman, S. (1977) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365517709091496 · Cited by 971
Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs
Reiber, H., & Peter, J. B. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00501-3 · Cited by 740
Qin, Y., Duquette, P., Zhang, Y., Talbot, P. J., Poole, R., & Antel, J. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3568 · Cited by 323
The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis
Reiber, H., Ungefehr, S., & Jacobi, C. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400304 · Cited by 305
McLean, B., Luxton, R. W., & Thompson, E. J. (1990) · Brain · doi:10.1093/brain/113.5.1269 · Cited by 206
Self-citationVandvik, B., Norrby, E., Nordal, H. J., & DECRÉ, M. (1976) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1976.tb03050.x · Cited by 194
A study of oligoclonal band negative multiple sclerosis.
Zeman, A. Z., Kidd, D. P., McLean, B., Kelly, M. A., Francis, D. A., Miller, D. H., Kendall, B. E., Rudge, P., Thompson, E. J., & McDonald, W. I. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.1.27 · Cited by 161
Self-citationIgG production within the central nervous system: A critical review of proposed formulae
Lefvert, A. K., & Link, H. (1985) · Annals of Neurology · doi:10.1002/ana.410170105 · Cited by 129
Oligoclonal IgG Bands in Cerebrospinal Fluid
Kostulas, V. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520220043014 · Cited by 119
O’Connor, K. C., Chitnis, T., Griffin, D. E., Piyasirisilp, S., Bar‐Or, A., Khoury, S. J., Wucherpfennig, K. W., & Hafler, D. A. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00002-x · Cited by 98
Cited by
Sorted by citations
Items 401–500 of 627
Diagnostic biomarkers in multiple sclerosis
Kuenz, B., Deisenhammer, F., Berger, T., & Reindl, M. (2007) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.1.2.225 · Cited by 5
Self-citationQuantified CSF antibody reactivity against myelin in multiple sclerosis
Sun, X., Bakhti, M., Fitzner, D., Schnaars, M., Kruse, N., Coskun, Ü., Kremser, C., Willecke, K., Kappos, L., Kühle, J., et al. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.264 · Cited by 5
Dobson, R., Feldmann, M., Thompson, A. J., Giovannoni, G., Miller, D. H., Thompson, E. J., Palmer, H. E., & Miller, R. F. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.226340.159 · Cited by 5
Self-citationFoesleitner, O., Kollmer, J., Weiler, M., Sam, G., Wildemann, B., Wick, W., Bendszus, M., Heiland, S., & Jäger, L. B. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1335408 · Cited by 4
Kliushnikova, D., Otto, F., Pilz, G., Wipfler, P., & Harrer, A. (2025) · Biomolecules · doi:10.3390/biom15010108 · Cited by 4
The Diagnostic Utility of Oligoclonal Bands in Multiple Sclerosis: A Time-Course Analysis
Candeloro, R., Ferri, C., Laudisi, M., Baldi, E., Pugliatti, M., & Castellazzi, M. (2025) · Biomedicines · doi:10.3390/biomedicines13020440 · Cited by 5
Revendová, K. Ž., Zeman, D., Kušnierová, P., Bunganic, R., Hanzlíková, P., Karasova, K., Volný, O., & Bar, M. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103847 · Cited by 5
Qiu, X., Liang, Y., Wei, Y., Lu, M., Mei, Y., Liu, B., Tang, Y., & Liang, J. (2024) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2024.108514 · Cited by 4
Higgins, V., Parker, M., Beriault, D. R., Mostafa, A., Estey, M. P., Agbor, T. A., & Ismail, O. Z. (2024) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2024.110855 · Cited by 4
Lauerer, M., Wiltgen, T., Brückner, C., Engl, C., Giglhuber, K., Lambrecht, S., Pongratz, V., Berthele, A., Gasperi, C., Kirschke, J. S., et al. (2025) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2024-335037 · Cited by 4
Younger, D. S. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98817-9.00007-7 · Cited by 4
A Survey of Cerebrospinal Fluid Total Protein Upper Limits in Canada: Time for an Update?
Bourque, P. R., McCudden, C. R., Warman‐Chardon, J., Brooks, J., Hegen, H., Deisenhammer, F., & Breiner, A. (2019) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2019.12 · Cited by 4
Self-citationMolecule of the month: miRNA and Multiple Sclerosis
Shapshak, P. (2013) · Bioinformation · doi:10.6026/97320630009847 · Cited by 4
Gillain, N., Fumal, A., Nève, C., Minon, J., & de Noordhout, A. M. (2009) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/j.immbio.2009.03.005 · Cited by 4
Boudet, S., Peyrodie, L., Wang, Z., & Forzy, G. (2016) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2016.7590809 · Cited by 4
Biomarkers of Disease Progression
Petzold, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-65921-3_6 · Cited by 4
Kamishina, H., Oji, T., Cheeseman, J. A., & Clemmons, R. M. (2008) · Veterinary Clinical Pathology · doi:10.1111/j.1939-165x.2008.00020.x · Cited by 4
Fainardi, E., Castellazzi, M., Bellini, T., & Dallocchio, F. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506070897 · Cited by 4
Anti-MOG syndrome: a road to be paved
Adoni, T. (2017) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20170147 · Cited by 4
Multiple sclerosis or multiple possibilities: The continuing problem of misdiagnosis
Deisenhammer, F. (2013) · Neurology · doi:10.1212/wnl.0b013e3182858cbc · Cited by 4
Self-citationBrain white matter damage biomarkers
Nabizadeh, F. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.11.005 · Cited by 3
Predicting intrathecal immunoglobulin synthesis in the ICU: a comparative study of IgG-based indexes
Balcerac, A., Marois, C., Sterlin, D., Rohaut, B., Demeret, S., Weiss, N., & Guennec, L. L. (2025) · Annals of Intensive Care · doi:10.1186/s13613-025-01475-7 · Cited by 3
Paul, P., Behzadirad, M., Al-Hallaf, R., Penuela, S. C. D., Pardo, C. A., Jie, C., Nourbakhsh, B., & Hamad, A. R. A. (2025) · Immunological Investigations · doi:10.1080/08820139.2025.2552841 · Cited by 3
Schmidauer, M., Berek, K., Auer, M., Bsteh, G., Cavalla, P., Pauli, F. D., Filippo, M. D., Deisenhammer, F., Emeršič, A., Föttinger, F., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1658182 · Cited by 3
Self-citationHegen, H., Andréasson, U., Archelos-Garcia, J.-J., Bachmaier, G., Blennow, K., Bsteh, G., Hubeek, I., Khalil, M., Kühle, J., Kuiperij, H. B., et al. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00747-5 · Cited by 3
Self-citationReal‐World Performance of CSF Kappa Free Light Chains in the 2024 McDonald Criteria
Leibowitz, M. M., Cooper, R., Kaninia, S., Challis, K., Greenway, W., Bonello, M., Elbahnasawi, M., Shode, D. T., Gajdasik, D., Iliev, V., et al. (2026) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70300 · Cited by 3
Lost in space, lost in time: A clinician’s proposed approach to the diagnosis of multiple sclerosis
Wafa, M., & Giovannoni, G. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.106989 · Cited by 3
Self-citationDiagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MS
Tournier, A., Gavoille, A., Pique, J., Levraut, M., Micoud, E., Maillart, É., Audoin, B., Demortière, S., Boutière, C., Ayrignac, X., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000214806 · Cited by 3
A review of laboratory practices for CSF oligoclonal banding and associated tests
Higgins, V., Chen, Y., Freedman, M. S., Rodríguez-Capote, K., & Beriault, D. R. (2025) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2025.2490166 · Cited by 3
Self-citationA 54-year-old woman with progressive gait disturbance and MRI abnormalities
Hochberg, F. H., Rodriguez, F., Atkinson, J. L. D., Shaw, E. G., Keegan, B. M., & Kantarci, O. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b1644d · Cited by 3
Serum neurofilament level as a biomarker in multiple sclerosis
Jabbar, H. Q., Hassoun, H. K., & Allebban, Z. (2024) · Neurology Asia · doi:10.54029/2024zij · Cited by 3
Marastoni, D., Sicchieri, M., Pizzini, F. B., Scartezzini, A., Virla, F., Turano, E., Anni, D., Bertolazzo, M., Ziccardi, S., Camera, V., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-12947-y · Cited by 3
Issues with Immunology and Serology Testing
Wahed, A., & Risin, S. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415783-5.00018-9 · Cited by 3
Immunoglobulins in Cerebrospinal Fluid
Sellebjerg, F. T. (2015) · Springer eBooks · doi:10.1007/978-3-319-01225-4_10 · Cited by 3
Self-citationForzy, G., Peyrodie, L., Boudet, S., Wang, Z., Vinclair, A., & Chieux, V. (2017) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2017.11.001 · Cited by 3
D’Cunha, A., Pandit, L., Malli, C., & Sudhir, A. (2021) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_508_20 · Cited by 3
Csákó, G. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8793-1_33 · Cited by 3
da Gama, P. D., de Alcantara, T. G., Smaniotto, R., Petuco, P. D. L., de Almeida, W. A., da Gama, R. A. D., & Fragoso, Y. D. (2022) · Case Reports in Neurological Medicine · doi:10.1155/2022/8999853 · Cited by 3
Hvaring, C., Alawad, N., Salvesen, Ø. O., Hovdal, H., White, L. R., & Boullerne, A. I. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104188 · Cited by 3
Emergence of antibodies as biomarkers in multiple sclerosis
Berger, T., & Reindl, M. (2005) · Future Neurology · doi:10.2217/14796708.1.1.57 · Cited by 3
Intrathecal Immunoglobulin Synthesis in MS—A Complete Reappraisal
Bonnan, M. (2016) · InTech eBooks · doi:10.5772/63201 · Cited by 3
Belimezi, M., Kalliaropoulos, A., Mentis, A. A., & Chrousos, G. P. (2021) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2021-207766 · Cited by 3
Guidelines on Cerebrospinal Fluid Analysis
Hegen, H., Teunissen, C. E., Sellebjerg, F. T., Tumani, H., & Deisenhammer, F. (2015) · Springer eBooks · doi:10.1007/978-3-319-01225-4_24 · Cited by 3
Self-citationBilateral vision loss responsive to corticosteroids
Lee, M. D., Song, B. J., Odel, J. G., & Sadun, A. A. (2012) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.05.006 · Cited by 3
Recherche de bandes oligoclonales dans le LCR
Puissant‐Lubrano, B., Clanet, M., & Blancher, A. (2011) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2011.09.004 · Cited by 3
Review of the Clinical Debate Regarding Interventions for Multiple Sclerosis
Ryan, M. A., Deno, S., & Zwibel, H. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.s1-b.1 · Cited by 3
Diagnosis of multiple sclerosis: what is changing?
Arrambide, G., & Tintoré, M. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1691530 · Cited by 3
Peña-Sánchez, M., O’Farrill, Z. L., Luna, L. V., Loza, M. B., García, S. G., Hernández-Díaz, Z. M., Saínz, M. C. M., Carriera, R. A. F., Eiriz, A. C., & González‐Quevedo, A. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102412 · Cited by 4
Risk Factors in Cause and Course of Multiple Sclerosis
Jafari, N. (2012) · RePub (Erasmus University Rotterdam) · Cited by 3
Villar, L. M., & Alvarez‐Cermeño, J. C. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511415890 · Cited by 3
Karussis, D. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803678-5.00295-2 · Cited by 6
Cerebrospinal fluid-specific oligoclonal bands in dogs with idiopathic epilepsy
Föhr, J., Prümmer, J. K., Maiolini, A., Marti, E., Jelčić, I., Vidondo, B., Ziegler, M., Bathen‐Nöthen, A., Tipold, A., Volk, H. A., et al. (2024) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.17265 · Cited by 3
The Etiological Spectrum of Acute Sensory Myelitis
Hyun, J., Kim, J. Y., Choi, K. G., Kim, H. J., & Park, K. D. (2015) · Journal of Clinical Neurology · doi:10.3988/jcn.2015.11.3.227 · Cited by 2
Maaloul, M., Mejdoub, S., Sakka, S., Hachicha, H., Dammak, M., Koubaa, F., Mhiri, C., Masmoudi, H., & Feki, S. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105509 · Cited by 2
Villa, A. M., Manín, A., Seimandi, C., Guerrero, D. A., & Ramos, G. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.106223 · Cited by 2
Relevance of Autoantibodies for the Classification and Pathogenesis of Neurological Diseases
Mader, S., Obholzer, B., & Reindl, M. (2011) · InTech eBooks · doi:10.5772/20517 · Cited by 2
Immunofixation Electrophoresis for Identification of Proteins and Specific Antibodies
Csákó, G. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8793-1_17 · Cited by 2
Thevarkalam, M., Krishnan, S., Shanmughan, L. I., Mathai, A., Leelamani, J. V., Kannoth, S., Bhaskaran, R., Iype, T., & Panda, S. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104717 · Cited by 2
Foesleitner, O., Sturm, V. J. F., Kollmer, J., Weiler, M., Sam, G., Wildemann, B., Wick, W., Bendszus, M., Heiland, S., & Jäger, L. B. (2023) · European Journal of Neurology · doi:10.1111/ene.16126 · Cited by 2
The Diagnosis of Multiple Sclerosis
Ganguly, K. (2006) · The AMA Journal of Ethic · doi:10.1001/virtualmentor.2006.8.2.cprl1-0602 · Cited by 2
Chabas, D., & Waubant, E. L. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511974373.016 · Cited by 2
The use of flow cytometry to assess a novel drug efficacy in multiple sclerosis
Benedek, G., Meza‐Romero, R., BOURDETTE, D. N., & Vandenbark, A. A. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9634-0 · Cited by 2
Biomarkers of Disease Progression
Petzold, A. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2395-8_7 · Cited by 2
From Immune Sanctuary to Neurological Battlefield: The Role of Neuroimmune Cells
Chakrabarti, S. K., & Chattopadhyay, D. (2024) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2024.00026 · Cited by 2
Differential Diagnosis and Diagnostic Criteria for Multiple Sclerosis
Marriott, J. J., & O'Connor, P. W. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6068-0.00002-4 · Cited by 2
Biochemical and immunological markers of multiple sclerosis
Seven, A., & Aslan, M. (2007) · Cited by 2
Oligoclonal Bands in Multiple System Atrophy: Case Report and Proposed Mechanisms of Immunogenicity
Neilson, L. E., Hollen, C., Hiller, A., & Wooliscroft, L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.852939 · Cited by 2
Prümmer, J. K., Stein, V. M., Marti, E., Ziegler, M., Lutterotti, A., Jelčić, I., Steffen, F., Buch, T., & Maiolini, A. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.873456 · Cited by 2
Biomarkers in Multiple Sclerosis
Ignatova, V. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106052 · Cited by 2
CSF testing for multiple sclerosis
Pender, M. P. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70151-4 · Cited by 2
Mielcarz, D. W., Bergeron, A. J., DeLong, J. K., Dias, A., Smith, K. M., Mack, K. L., Kasper, L. H., & Channon, J. Y. (2022) · medRxiv · doi:10.1101/2022.02.25.22270266 · Cited by 2
Methods for Biomarker Analysis
Franciotta, D. M., Alessio, M., Garzetti, L., & Furlan, R. (2015) · Springer eBooks · doi:10.1007/978-3-319-01225-4_13 · Cited by 1
Назаров, В. Д., Сергеевич, М. Г., Маzing, A. V., Суркова, Е. А., Сергеевич, К. В., Shumilina, M. V., Totolyan, N. A., Evdoshenko, E. P., Lapin, S. V., Emanuel, V. L., et al. (2018) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-018-0617-1 · Cited by 1
Cerebrospinal fluid (CSF) analysis and role in clinical neurology
Aggarwal, J., Singh, S., & Rawat, A. (2021) · International Journal of Clinical Biochemistry and Research · doi:10.18231/j.ijcbr.2021.016 · Cited by 1
Tian, J., Liu, X., Li, Y., Gu, Y., Deng, B., Yang, W., Yu, H., Zhang, X., & Chen, X. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120145 · Cited by 1
Fluorometric Nanoscale Analysis of Bilirubin and Biliverdin in Human Cerebrospinal Fluid
Sist, P., Tramer, F., Sartori, A., Manganotti, P., & Passamonti, S. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00265 · Cited by 1
KFLC to Total CSF Protein Ratio Is an Alternative to KFLC Index to Diagnose Multiple Sclerosis
Moschetti, E., Venet, M., Thibaudin, L., Carla-Moreau, A., Gonzalo, P., Camdessanché, J., & Tholance, Y. (2025) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200451 · Cited by 1
Castellazzi, M., Ferrara, M. C., Arosio, B., Lozano-Vicario, L., Pinardi, E., Ornago, A. M., Okoye, C., Martínez‐Velilla, N., Bellelli, G., & Volpato, S. (2025) · Biomarker Insights · doi:10.1177/11772719251385928 · Cited by 1
Gözgöz, H., Orhan, O., Konuk, B. A., & Akan, P. (2025) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaf119 · Cited by 1
Effects of Biological Sex and Age on Cerebrospinal Fluid Markers—A Retrospective Observational Study
Hafer, I., Faissner, S., Gold, R., & Haghikia, A. (2026) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70307 · Cited by 1
Higgins, V., Parker, M., Ahmed, B., Bhayana, V., Booth, R. A., Chen, Y., Collier, C., Freedman, M. S., Gagné, M., Ismail, O. Z., et al. (2026) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2026.111098 · Cited by 1
Self-citationKappa free light chain index in CSF diagnostics: the impact of different immunoglobulin isotypes
Schmidauer, M., Berek, K., Auer, M., Pauli, F. D., Föttinger, F., Krajnc, N., Deisenhammer, F., Bsteh, G., Walde, J. F., & Hegen, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1747659 · Cited by 1
Self-citationThe Prognostic Value of Paramagnetic Rim Lesions in People With Multiple Sclerosis
Lauerer, M., Voon, C. C., McGinnis, J., Sepp, D., Meineke, J., Wiltgen, T., Berg, R., Preibisch, C., Wiestler, B., Engl, C., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000218428 · Cited by 1
Diagnosing multiple sclerosis: implementation and unintended effects of the 2024 McDonald criteria
Foster, M. A., Wade, C., Ford, H. L., & Schmierer, K. (2026) · Brain · doi:10.1093/brain/awag293 · Cited by 1
Corsini, E., Biagioli, T., Buoro, S., Cazzaniga, F. A., MOLIN, S. D., Dolci, A., Michetti, L., Fabio, M. O. D. A., Mussap, M., Natali, P., et al. (2026) · Biochimica Clinica · doi:10.23736/s0393-0564.26.00189-5 · Cited by 1
Value of oligoclonal band study in clinically isolated syndromes and multiple sclerosis
Alvarez-Cermeño, J. C., Gasalla, T., & Villar, L. M. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.9.1279 · Cited by 1
K Index in cerebrospinal fluid: a valid tool in multiple sclerosis diagnosis
Pieri, M., Duranti, F., Centonze, D., Buttari, F., Bernardini, S., & Dessı̀, M. (2014) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.1007/s13631-014-0072-0 · Cited by 1
Body fl uid biomarkers in multiple sclerosis
Comabella, M. (2014) · Cited by 1
Acquired Disorders Affecting the White Matter
Makhani, N., Brenton, J. N., & Banwell, B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-37101-8.00100-4 · Cited by 1
Defer, G. L., Brochet, B., & Pelletier, J. (2010) · Elsevier eBooks · doi:10.1016/b978-2-294-70469-7.00002-2 · Cited by 1
Multiple myeloma with Echinococcus granulosus infection diagnosed by detection of oligoclonal bands
Li, J., Zhang, X., Hao, H.-J., Fan, S., & Xu, Y. (2021) · Medicine · doi:10.1097/md.0000000000024709 · Cited by 1
Hegen, H., & Deisenhammer, F. (2021) · Neuromethods · doi:10.1007/978-1-0716-1319-1_3 · Cited by 1
Self-citationNarayan, R., Stüve, O., & Shah, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-62539-5.00046-1 · Cited by 3
Tolkovsky, A., Pardo, K., Hellmann, M. A., Lotan, I., Auriel, E., & Wilf‐Yarkoni, A. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105554 · Cited by 1
Utilizing metabolomic profiling as a supportive diagnostic tool for radiologically isolated syndrome
Tarhan, G., Domaç, S. F., Selek, Ş., Gül, A. Z., & Demir, S. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.106250 · Cited by 1
Multiple Sklerose und andere autoimmune ZNS-Erkrankungen
Kroner, A., Kleinschnitz, C., Stadelmann, C., Raab, P., Stangel, M., Trebst, C., Voß, E. V., & Cordes, A.-L. (2011) · Springer eBooks · doi:10.1007/978-3-642-20477-7_1 · Cited by 1
Elevated cerebrospinal fluid IgG index in acute cerebellitis presenting with sudden onset headache
Lee, K. Y., & Lee, K.-S. (2014) · Cited by 1
Revisting Cerebrospinal Fluid (CSF) Examination
Yap, C. Y., & Aw, T. C. (2010) · Proceedings of Singapore Healthcare · doi:10.1177/201010581001900413 · Cited by 1
Bandas oligoclonales: aporte e interpretación en pacientes con sospecha de esclerosis multiple
Jarmi, V., de Elías, R., Kiener, O., Villate, S., Vrech, C., & Barzón, S. (2015) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 1
Diagnosis of Multiple Sclerosis: 2017 McDonald Diagnostic Criteria
Sohn, E. H., & Jeong, S.-H. (2018) · Journal of the Korean Neurological Association · doi:10.17340/jkna.2018.4.1 · Cited by 2
Metadata
- Authors
- Freedman, M. S., Thompson, E. J., Deisenhammer, F., Giovannoni, G., Grimsley, G., Keir, G., Öhman, S., Racke, M. K., Sharief, M., Sindic, C. J. M., Sellebjerg, F., & Tourtellotte, W. W.
- Affiliations
- University of Ottawa (CA)
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2005-06-01
- Volume
- 62
- Issue
- 6
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2123646700
- Cited by
- 41
- References
- 34
- Citations by year
- 2023: 1 · 2020: 3 · 2018: 2 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 3 · 2012: 5
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Neurology (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- multiple sclerosis, cerebrospinal fluid analysis, diagnostic criteria, IgG index, isoelectric focusing, magnetic resonance imaging, evoked potentials, diagnostic standardization, false diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
